(Q34016030)

30 July 2017

1 reference

title

Ceftaroline: a cephalosporin with expanded Gram-positive activity (English)

1 reference

30 July 2017

main subject

gram-positive bacteria

0 references

2

G Ralph Corey

1 reference

30 July 2017

Zeina A Kanafani

1

1 reference

30 July 2017

publication date

1 February 2009

1 reference

30 July 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

30 July 2017

volume

4

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

25-33

1 reference

Giuseppe Brotzu and the discovery of cephalosporins.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

TAK-599, a novel N-Phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.4.1.25

21 January 2018

Identifiers

DOI

10.2217/17460913.4.1.25

1 reference

30 July 2017

1 reference